Cuilan Li/LinkedIn
Nov 19, 2025, 15:56
Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
Cuilan Li, Founder and CEO at You First Consulting, shared on LinkedIn:
”Today I had the chance to contribute my expertise in hematology and oncology to a cutting-edge project in Polycythemia Vera (PV).
It was insightful, forward-thinking, and a powerful reminder of how real-world clinical insights empower the next wave of pharmaceutical and technology-driven innovation.
Proud to support projects that move science forward and strengthen clinical excellence.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 15:19Dip Ghosh: Understanding Blood – From Sample to Diagnosis
-
May 27, 2026, 15:14Jeremiah Bernier-Latmani: Could Angpt2 Blockade Become a New Treatment for GI Bleeding in VWD
-
May 27, 2026, 15:11Paolo Zamboni: How Female Steroid Metabolism Triggers Lipedema?
-
May 27, 2026, 14:56Veronica Sanchez: Risk Factors and How to Recognize the Signs of Preeclampsia
-
May 27, 2026, 14:45Suvro Sankha Datta: New Frontiers in Platelet Transfusion and Preservation
-
May 27, 2026, 14:30Stacey Black Watson: A Meaningful Gathering Focused on Genetic Aortic and Vascular Conditions
-
May 27, 2026, 14:27Abdullah Mohsin: Possible Nursing Interventions for a Patient with DVT
-
May 27, 2026, 14:21Emmanuel J Favaloro: 100 Years of Von Willebrand disease
-
May 27, 2026, 14:20Noemy E. Diaz-Burgos: A Memorable Opening to the WFH Congress in Kuala Lumpur